Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Massimi, Isabella ^a   Ciuffetta, Ambra ^b   Temperilli, Flavia ^a   Ferrandino, Francesca ^b   Zicari, Alessandra ^a   Pulcinelli, Fabio M ^a   Felli, Maria Pia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; MULTIDRUG RESISTANCE PROTEIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; ABCC4 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; BYPASS SURGERY; CELL DAMAGE; CELL DEATH; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DENSITOMETRY; DRUG CYTOTOXICITY; DRUG ELIMINATION; EMBRYO; EUKARYOTIC CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; TRYPAN BLUE ASSAY; UPREGULATION; WESTERN BLOTTING; CELL LINE; CELL SEPARATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE; TRANSPORT AT THE CELLULAR LEVEL;

ASPIRIN; BIOLOGICAL TRANSPORT; BLOOD PLATELETS; CELL DEATH; CELL LINE; CELL SEPARATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PPAR ALPHA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84944258522     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/607957     Document Type: Article

References (26)

1. O. Fardel, L. Payen, A. Courtois, L. Vernhet, and V. Lecureur, "Regulation of biliary drug efflux pump expression by hormones and xenobiotics," Toxicology, vol. 167, no. 1, pp. 37-46, 2001
2. C. D. Klaassen and L. M. Aleksunes, "Xenobiotic, bile acid, and cholesterol transporters: function and regulation," Pharmacological Reviews, vol. 62, no. 1, pp. 1-96, 2010
3. K. W. Scotto, "Transcriptional regulation of ABC drug transporters," Oncogene, vol. 22, no. 47, pp. 7496-7511, 2003
4. C. Xu, C. Y. T. Li, and A. N. T. Kong, "Induction of phase I, II and III drug metabolism/transport by xenobiotics," Archives of Pharmacal Research, vol. 28, no. 3, pp. 249-268, 2005
5. D. Türk, M. D. Hall, B. F. Chu et al., "Identification of compounds selectively killing multidrug-resistant cancer cells," Cancer Research, vol. 69, no. 21, pp. 8293-8301, 2009
6. B. C. Baguley, "Multiple drug resistance mechanisms in cancer," Molecular Biotechnology, vol. 46, no. 3, pp. 308-316, 2010
7. J.-P. Gillet, T. Efferth, D. Steinbach et al., "Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes," Cancer Research, vol. 64, no. 24, pp. 8987-8993, 2004
8. M. M. Gottesman, C. Cardarelli, S. Goldenberg, T. Licht, and I. Pastan, "Selection and maintenance of multidrug-resistant cells," Methods in Enzymology, vol. 292, pp. 248-258, 1998
9. F. G. M. Russel, J. B. Koenderink, and R. Masereeuw, "Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules," Trends in Pharmacological Sciences, vol. 29, no. 4, pp. 200-207, 2008
10. T. Mattiello, R. Guerriero, L. V. Lotti et al., "Aspirin extrusion from human platelets through multidrug resistance protein-4-Mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting," Journal of the American College of Cardiology, vol. 58, no. 7, pp. 752-761, 2011
11. B. D. Furmanski, S. Hu, K. I. Fujita et al., "Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinib," Clinical Cancer Research, vol. 19, no. 16, pp. 4359-4370, 2013
12. I. Massimi, R. Guerriero, L. V. Lotti et al., "Aspirin influences megakaryocytic gene expression leading to upregulation of multidrug resistance protein-4 in human platelets," British Journal of Clinical Pharmacology, vol. 78, no. 6, pp. 1343-1353, 2014
13. R. J. Anderson, D. E. Potts, P. A. Gabow, B. H. Rumack, and R. W. Schrier, "Unrecognized adult salicylate intoxication," Annals of Internal Medicine, vol. 85, no. 6, pp. 745-748, 1976
14. L. F. Prescott, M. I. Balali-Mood, J. A. Critchley, A. F. Johnstone, and A. T. Proudfoot, "Diuresis or urinary alkalinisation for salicylate poisoning" BritishMedical Journal, vol. 285, no. 6352, pp. 1383-1386, 1982
15. W. Snodgrass, B. H. Rumack, R. G. Peterson, and M. L. Holbrook, "Salicylate toxicity following therapeutic doses in young children," Clinical Toxicology, vol. 18, no. 3, pp. 247-259, 1981
16. A. R. Temple, "Acute and chronic effects of aspirin toxicity and their treatment," Archives of Internal Medicine, vol. 141, no. 3, pp. 364-369, 1981
17. B. S. Anand, J. J. Romero, S. K. Sanduja, and L. M. Lichtenberger, "Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects," American Journal of Gastroenterology, vol. 94, no. 7, pp. 1818-1822, 1999
18. R. N. DuBois, F. M. Giardiello, and W. E. Smalley, "Nonsteroidal antiinflammatory drugs, eicosanoids, and colorectal cancer prevention," Gastroenterology Clinics of North America, vol. 25, no. 4, pp. 773-791, 1996
19. R. Subbegowda and T. O. Frommel, "Aspirin toxicity for human colonic tumor cells results fromnecrosis and is accompanied by cell cycle arrest," Cancer Research, vol. 58, no. 13, pp. 2772-2776, 1998
20. M. Rius, J. Hummel-Eisenbeiss, and D. Keppler, "ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4)," Journal of Pharmacology and ExperimentalTherapeutics, vol. 324, no. 1, pp. 86-94, 2008
21. A. Barbarulo, P. Grazioli, A. F. Campese et al., "Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription," Journal of Immunology, vol. 186, no. 11, pp. 6199-6206, 2011
22. C. Cerletti, G. Dell'Elba, S. Manarini et al., "Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes," Clinical Pharmacokinetics, vol. 42, no. 12, pp. 1059-1070, 2003
23. J. M. Maher, L. M. Aleksunes, M. Z. Dieter et al., "Nrf2-and PPAR alpha-mediated regulation of hepatic mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid," Toxicological Sciences, vol. 106, no. 2, pp. 319-328, 2008
24. F. M. Pulcinelli, P. Pignatelli, A. Celestini, S. Riondino, P. P. Gazzaniga, and F. Violi, "Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients," Journal of the American College of Cardiology, vol. 43, no. 6, pp. 979-984, 2004
25. M. Ansari, G. Sauty, M. Labuda et al., "Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia," Blood, vol. 114, no. 7, pp. 1383-1386, 2009
26. C. M. Vallet, B. Marquez, N. Nhiri et al., "Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin," Toxicology, vol. 290, no. 2-3, pp. 178-186, 2011.